578 filings
Page 6 of 29
8-K
albyk
7 May 15
Raptor Pharmaceutical Reports First Quarter 2015 Financial Results and Provides Corporate Update
12:00am
DEFA14A
l92 76bsfn8
5 May 15
Additional proxy soliciting materials
12:00am
EFFECT
0oqnfp
30 Apr 15
Notice of effectiveness
12:00am
POS AM
i7dc83ohyy yx1i3ju
15 Apr 15
Prospectus update (post-effective amendment)
12:00am
8-K
vk7 xijmkzg
3 Apr 15
Other Events
12:00am
424B5
oho5r9s4uzlkv
2 Apr 15
Prospectus supplement for primary offering
12:00am
S-3ASR
kjdcw 6vtel3vin63
30 Mar 15
Automatic shelf registration
12:00am
EFFECT
uzwasgvxqp5jxatsypg6
30 Mar 15
Notice of effectiveness
12:00am
424B5
da9coxrvprz
30 Mar 15
Prospectus supplement for primary offering
12:00am
CORRESP
mo2 rwvgt06myppmjflp
26 Mar 15
Correspondence with SEC
12:00am
DEFA14A
lb3lq
26 Mar 15
Additional proxy soliciting materials
12:00am
UPLOAD
jqfq 82dbnoq2bop
10 Mar 15
Letter from SEC
12:00am
S-8
2zvh7t xczv87sd48
6 Mar 15
Registration of securities for employees
12:00am
POS AM
im8jff6
2 Mar 15
Prospectus update (post-effective amendment)
12:00am
POSASR
3w9fsof
2 Mar 15
Automatic shelf registration (post-effective amendment)
12:00am
8-K
5v1wm9it3 1gudk8b
26 Feb 15
Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2014 Financial Results and Provides 2015 Corporate Update
12:00am
8-K
2yq 4hp0ltqk
13 Feb 15
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
12:00am
8-K
vwke3
7 Jan 15
Raptor Pharmaceutical Appoints Krishna Polu, M.D. as Chief Medical Officer and Michael Smith as Chief Financial Officer
12:00am